Cellular transplantation is emerging as a potential mechanism with which to augment
myocyte number in diseased hearts. To date a number of cell types have been shown to …

Myocardial infarction is the leading cause of congestive heart failure and death in the
industrialized world. Current therapy is limited in preventing the progression of ventricular …

BACKGROUND: Cellular replacement strategies using embryonic stem cells (ESCs) and
their cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …

Objectives: We report histological analysis of hearts from patients with end-stage heart
disease who were transplanted with autologous skeletal myoblasts concurrent with left …

Stem cells provide an alternative curative intervention for the infarcted heart by
compensating for the cardiomyocyte loss subsequent to myocardial injury. The presence of …

A growing number of studies are reporting beneficial effects of the transplantation of alleged
cardiac stem cells into diseased hearts after myocardial infarction. However, the …

Background The feasibility of successfully grafting fetal cardiomyocytes into infarcted
myocardium is now established, but the functional effects of such a procedure still remain …

Objectives: Transplantation of fetal cardiomyocytes improves function of infarcted
myocardium but raises availability, immunologic, and ethical issues that justify the …

BACKGROUND: Previous studies have suggested that autologous skeletal myoblast
transplantation (ASMT) improves left ventricular (LV) function in small animals after …

Cellular cardiomyoplasty (CCM), or introduction of immature cells into terminally injured
heart, can mediate repair of chronically injured myocardium. Several different cell types …